Drug intelligence / Profile preview

nicotine + prazosin

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral, Transdermal, Inhalation, Intranasal, Sublingual
01

Overview

Nicotine + prazosin is a combination of two small molecule drugs, each with distinct mechanisms of action. Nicotine is a stimulant that acts as an agonist at various neuronal nicotinic acetylcholine receptors, leading to increased dopamine release and stimulation of the central and peripheral nervous systems. Prazosin is an alpha-1 adrenergic receptor antagonist that causes vasodilation by blocking the vasoconstrictive effects of catecholamines on blood vessels, primarily used for hypertension. The combination has been studied in preclinical models for its effects on nicotine withdrawal symptoms and may have potential utility in smoking cessation or modulating cardiorespiratory responses to nicotine[3][7][9].

02

Targets

α4β2 nAChR (Nicotinic acetylcholine receptor alpha4 beta2 subtype)ADRA2A (α2A)ADRA1D (α1D)CHRNA7 (α7 nicotinic receptor)ADRA1A (α1A)ADRA1B (α1B)

Beyond the preview

Go deeper on nicotine + prazosin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on nicotine + prazosin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call